Methods of Using Mir-199a As a Marker and Sequences of Mir-199a As a Therapeutic for Cancer
The invention relates to methods of measuring the level of expression of differentially expressed microRNAs (miRNAs), such as for example hsa-mir-199a, in a cancer cell as an indicator of the level of chemoresistance of the cancer cell. The invention further relates to methods of administering a nucleic acid, having a sequence based upon the sequence of a differentially expressed miRNA, such as for example hsa-mir-199a, to a cancer cell to diminish the chemoresistance of the cancer cell.
MOR GUILLERMO G [US]; WEIDHAAS JOANNE [US]
Type of Offer:
« More Biotech Patents